What is ibogaine? FDA to fast-track review of drugs for mental health
Donald Trump
A mind-bending hallucinogen is moving out of the counterculture and into the clinic. The Food and Drug Administration on Friday greenlit the first-ever human clinical trial of an ibogaine derivative in the US, opening the door to testing the psychedelic drug as a potential treatment for alcohol-use disorder. The move comes just days after President Donald Trump signed an executive order aimed at fast-tracking psychedelic research and expanding access for people struggling with mental illness. “
din zilele anterioare